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Abstract
Background The aim of this study, conducted in 2006, was to
find out whether changes in sedation management in German
intensive care units took place in comparison with our survey
from 2002.
Methods We conducted a follow-up survey with a descriptive
and comparative cross-sectional multi-center design. A postal
survey was sent between January and May 2006, up to four
times, to the same 269 hospitals that participated in our first
survey in 2002. The same questionnaire as in 2002 was used
with a few additional questions.
Results Two hundred fourteen (82%) hospitals replied. Sixty-
seven percent of the hospitals carried out changes in sedation
management since the 2002 survey. Reasons for changes were
published literature (46%), national guidelines (29%), and
scientific lectures (32%). Sedation protocols (8% versus 52%)
and a sedation scale (21% versus 46%) were used significantly
more frequently. During sedation periods of up to 24 hours,
significantly less midazolam was used (46% versus 35%). In
comparison to 2002, sufentanil and epidural analgesia were
used much more frequently in all phases of sedation, and
fentanyl more rarely. For periods of greater than 72 hours,
remifentanil was used more often. A daily sedation break was
introduced by 34% of the hospitals, and a pain scale by 21%.
Conclusion The increased implementation of protocols and
scoring systems for the measurement of sedation depth and
analgesia, a daily sedation break, and the use of more short-
acting analgesics and sedatives account for more patient-
oriented analgesia and sedation in 2006 compared with 2002.
Introduction
Most mechanically ventilated patients require analgesia and
sedation. Adequate analgesia and sedation should ensure that
the patient can receive intensive medical care without undue
stress or pain [1]. As with insufficient sedation, excessively
deep sedation also may lead to increased morbidity, increased
costs, and a prolonged stay in the intensive care unit (ICU) [2-
4]. Recent advances with drugs that are more controllable,
better ventilation techniques and sedation strategies, and the
use of scoring systems and sedation protocols enable optimi-
zation of sedation [1,5,6]. However, the optimal sedation strat-
egy remains a controversial issue at present. Despite
controversies, a shift from deeper to lighter sedation, thereby
maintaining the normal circadian rhythm, is emerging within
the published literature [1,5,7].
Apart from sedation, emphasis should be placed on adequate
monitoring of analgesia. Whipple and colleagues [8] have
shown that 70% of patients admitted to an ICU recollected
suffering pain. Regular review of pain scores followed by
appropriate therapy leads to a reduction in morbidity and a
reduction in duration of mechanical ventilation [9].
Soliman and colleagues [10] have shown that sedation prac-
tice and the use of differing scoring systems and guidelines
are quite different between countries. In 2002, a national sur-
vey of analgesia and sedation practice in German ICUs was
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undertaken [11]. The goal of the present study was to find out
whether new trends or significant changes in ICU analgesia
and sedation practice among mechanically ventilated patients
in ICUs have emerged since the last survey [11] and the pub-
lication of national guidelines for analgesia and sedation prac-
tice in Germany in 2005 [12]. The major recommendations of
the guidelines consist of the application of scores for analge-
sia and sedation, with a patient-oriented depth of sedation,
implementation of written sedation protocols, application of
short-acting drugs, and use of regional anesthesia techniques.
Materials and methods
This study is a descriptive, comparative, multi-center follow-up
study to the survey performed in 2002 [11]. The same address
database was used as in the first study. In total, 254 general
hospitals and 15 university hospitals were contacted. All ICUs
were run by an anesthesiological department and include sur-
gical and interdisciplinary adult ICUs. The survey was submit-
ted to the chairmen of the departments up to four times in the
period January to May 2006. The response rate was 82% and
most of the forms were filled out by the head of the ICU. The
questionnaire corresponded to the first questionnaire,
although a few questions were added.
The questionnaire
A modified version of the questionnaire used in 2002 [11] was
used. Questions were added relating to the use of pain scores
[9], daily sedation breaks [2,13], and the reasons for any
changes in sedation practice. Since no department used a val-
idated instrument to score for delirium in the previous survey,
we did not ask about delirium in the present questionnaire.
Part 1: General data
General data included size and type of ICU, number of beds,
case mix index, number of days in the ICU, average length of
stay, number of mechanically ventilated patients per year, and
average duration of ventilation.
Part 2: Data relating to analgesia and sedation
These data included changes accomplished in sedation man-
agement since 2002, use of scores for pain severity and seda-
tion depth, daily sedation break, implementation of written
protocols, reasons for choice of medications used, and use of
muscle relaxants.
Part 3: Questions relating to changes in analgesia and 
sedation practice occurring since the last survey
These questions focused on reasons for any potential
changes that had occurred in the interim period between this
survey and the 2002 survey.
Part 4: Pharmacological and regional analgesia techniques 
for analgesia and sedation
As was the case with the first survey, the sedation periods
were divided into the following groups according to the Amer-
ican [14] and German [12] guidelines: sedation up to 24
hours, 24 to 72 hours, greater than 72 hours, and analgesia
and sedation during weaning from mechanical ventilation.
Statistics
Data were collected in a Microsoft Access 2002 database
and analyzed with Microsoft Excel 2002 (Microsoft Corpora-
tion, Redmond, WA, USA) and SPSS for Windows (version
13.0; SPSS Inc., Chicago, IL, USA). Responses to part 2 of
the questionnaire were given as 'yes' or 'no'. Responses to
parts 3 and 4 may include more than one answer. Univariate
statistical analyses were carried out depending on the scaling
of the data, using either the Mann-Whitney U test or the chi-
square test. Analyses were assigned as exploratory. Therefore,
no multiple adjustments were carried out. Statistical signifi-
cance (in the sense of exploratory analyses) was set at a p
value of greater than 0.05.
Results
The response rate was 82% (214 out of 261). More than 90%
of the ICUs that responded in 2002 also participated in this
survey. At this rate of response, non-responder bias is insignif-
icant [15]. There was no significant difference to the 2002 sur-
vey response rate (82%). All data were entered into the
analyses. In regard to general data (Table 1), there were signif-
icant differences in the number of ICU beds in university hos-
pitals and in general hospitals (9 versus 10) and also in the
Table 1
General data of the surveyed intensive care units in 2002 and 2006
2002 Median (minimum, maximum) 2006 Median (minimum, maximum) P value
Intensive care beds (university hospitals) 14 (8, 24) 24 (10, 32) 0.09
Intensive care beds (general hospitals) 9 (2, 27) 10 (4, 40) 0.02
Patients per year (university hospitals) 1,481 (517, 2,500) 2,000 (700, 2,860) 0.2
Patients per year (general hospitals) 930 (120, 5,297) 1,000 (120, 4,578) 0.03
Nursing care days (university hospitals) 4,950 (2,000, 7,900) 5,000 (3,000, 13,900) 0.5
Nursing care days (general hospitals) 2,704 (400, 7,830) 3,000 (250, 15,462) 0.06
The Mann-Whitney U test was used to calculate p values.Available online http://ccforum.com/content/11/6/R124
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number of patients treated annually (9,330 versus 1,000).
Process data
Whereas only 8% of hospitals used a sedation scale in the first
survey, this number rose to 51% in the present survey. We do
not know how these scales were directed at the individual
patient level in terms of comparing target and actual sedation
levels. The Ramsay sedation scale (RSS) [16] was used
almost exclusively, and only one hospital referred to use of the
Richmond agitation sedation scale (RASS) [17]. Only numeric
rating scales and visual analogue scales were used as a pain
scale. Furthermore, sedation protocols were employed signifi-
cantly more often (by 46% of respondents compared with
21% in the first survey). Oral procedure instructions (depart-
mental consensus) were introduced in 93% of the surveyed
hospitals, and this differed significantly from the first survey.
Eighty-eight percent of the hospitals endeavored to maintain a
day-night rhythm (Table 2).
Changes in analgesia and sedation practice
Sixty-seven percent (95% confidence interval: 37% to 97%)
of hospitals changed analgesia and sedation practice in the
years 2002 to 2006. Reasons given for these changes ranged
from the publication of the S2e guidelines (29%) to educa-
tional lectures (32%). The most frequently quoted reason
resulting in a change in analgesia and sedation policy was
studying current literature (46%). The reasons for the changes
are summarized in Table 3. Pain scoring, although not
surveyed in 2002, was found to be in use in 21% of cases.
Thirty-four percent of respondents had introduced a daily
sedation break (Table 4).
Medications and techniques
Only medications or interventions used by more than 5% of
the respondents in any of the time periods were considered.
Sedatives
Propofol was used most frequently for sedation up to 24 hours
(83%). Midazolam was used significantly less frequently dur-
ing this period than in the 2002 survey (46% versus 35%). In
regard to periods of greater than 72 hours and weaning, use
of sedatives did not change (Tables 5 and 6).
Analgesics
Fentanyl was applied less frequently in all phases of sedation
compared with the first survey. In the present survey, sufentanil
was used significantly more often in all stages. For all periods
of longer than 24 hours, remifentanil was more commonly
ordered, with the greatest increases in the phases of 24 to 72
hours (6% versus 15%) and during weaning (2% versus 8%).
The rates of application of morphine, piritramide, or non-steroi-
dal anti-inflammatory drugs were comparable (Tables 5 and 6).
Adjuvant techniques for analgesia and sedation
With regard to the use of clonidine, there was no difference
compared with the 2002 survey. Ketamine (S) was signifi-
cantly more commonly used in the interim, particularly in the
case of long-term sedation greater than 72 hours (7% versus
15%) and also during weaning (20% versus 26%). Patient-
controlled analgesia techniques are now significantly more
widely applied during weaning than in 2002 (16% versus
22%). Similar to the earlier survey, neuromuscular blockade
was not performed regularly during any of the sedation phases
(Tables 5 and 6).
Regional analgesia techniques
Epidural analgesia was observed more frequently in all stages
of sedation compared with the preliminary investigation.
Peripheral nerve blocks were also performed significantly
more often for stays of greater than 72 hours and during wean-
ing. Patient-controlled epidural analgesia was applied more
often during short-term sedation periods (less than 24 hours)
in the 2006 survey than in that of 2002 (Tables 5 and 6).
Discussion
The goal of the present survey was to clarify whether a change
has taken place in analgesia and sedation practice since the
last survey in 2002 and after the publication of national prac-
tice guidelines on the subject [12]. Underlying the same ques-
tionnaire as in 2002, we are able to compare and contrast our
Table 2
Sedation practices in 2002 and 2006
2002 (n = 220) 2006 (n = 214) P value
Percentage (95% CI)
Sedation score 8 (-4 to 20) 51 (41 to 60) <0.001
Sedation protocol 21 (9 to 32) 46 (36 to 56) <0.001
Medication selection according to sedation duration 92 (88 to 96) 93 (89 to 97) 0.5
Oral procedure instructions 44 (33 to 53) 93 (89 to 97) <0.001
Day-night rhythm 81 (75 to 87) 88 (84 to 94) <0.001
Consideration of costs affecting drug selection 62 (54 to 70) 55 (46 to 64) 0.4
The chi-square test was used to calculate p values. CI, confidence interval; n, number of positive answers.Critical Care    Vol 11 No 6    Martin et al.
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findings. The most striking results are the significantly
increased use of sedation scales and written sedation
protocols.
The RSS [16] was the scale most frequently used in the
present survey, with only one institution employing the RASS
[17]. In recent reviews, Fraser and Rieker [18,19] demon-
strated that only the consistent use of a validated sedation
scale led to a reduction in the duration of mechanical ventila-
tion, as well as reduced length of ICU stay. Written sedation
guidelines were used significantly more often in the present
survey. Employment of sedation guidelines enables reductions
in both duration of mechanical ventilation and use of intensive
care time [20], with consequent savings in medical costs [21].
However, as shown by Elliott and colleagues [22] and
Andrews and colleagues [23], these positive changes are
achieved only with sufficient training of the personnel involved
and with adaptation of the guidelines to the local hospital envi-
ronment. Meanwhile, a daily sedation break, as suggested by
Kress and coworkers [2], is currently employed in one third of
our surveyed hospitals. In addition, pain monitoring is increas-
ingly performed. Chanques and colleagues [9] have pointed
out that by monitoring and optimizing pain management, the
number of nosocomial infections and the length of mechanical
ventilation can be reduced. The use of analgesia and sedation
scales, as well as the use of written guidelines, should result
in avoidance of oversedation of patients, as described by Mar-
tin and colleagues [24].
As with the Danish follow-up questionnaire on sedation and
analgesia in the ICU [25], a trend is being observed in Ger-
many toward the application of analgesics and sedatives that
are more controllable. For sedation periods of less than 72
hours, midazolam is used significantly less frequently than in
2002. Carson and colleagues [26] have shown the more favo-
rable pharmacokinetics of propofol versus benzodiazepines. In
terms of analgesics, the same development emerges. Fentanyl
is used less frequently in all stages of sedation, but sufentanil
is increasingly used. Remifentanil was applied more often for
sedation periods of up to 24 hours, sedation for less than 72
hours, and during weaning. Breen and colleagues [27] and
Muellejans and colleagues [28] have shown that using
remifentanil in that way leads to a significantly shortened ven-
tilation time compared with a control group. Ketamine (S) was
more frequently used in the phases up to 24 hours and from
24 to 72 hours than in 2002. However, as has been shown by
Ostermann and colleagues [29], there has been very little
investigation of long-term use of ketamine sedation. Neverthe-
less, an important reason favoring the use of ketamine is the
absence of a significant effect on bowel motility [30].
Epidural analgesia was performed more frequently in the
phases of greater than 72 hours and during weaning than in
Table 3
Reasons given for changes in sedation management since the last survey (2002)
Changes in sedation management Percentage (95% CI) n = 214
Resulting from S2e guidelines 29 (18 to 40)
Resulting from change in department leadership 10 (-3 to 23)
Following lectures 32 (21 to 42)
Following literature 46 (36 to 56)
Other 13 (-6 to 32)
CI, confidence interval; n, number of positive answers.
Table 4
Changes accomplished in sedation management since 2002
Changes Percentage (95% CI) n = 214
Sedatives changed 33 (22 to 44)
Analgesia changed 31 (20 to 42)
Regional techniques introduced 19 (7 to 31)
Pain scoring introduced 21 (9 to 33)
Daily sedation break 34 (23 to 45)
Sedation protocol implemented 23 (11 to 35)
Other 4 (-9 to 17)
CI, confidence interval; n, number of positive answers.Available online http://ccforum.com/content/11/6/R124
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the survey of 2002. As has been shown by Brodner and col-
leagues [31] and in the meta-analysis by Rodgers and col-
leagues [32], the perioperative use of epidural analgesia leads
to both shortening of intensive care stay as well as lowering
the incidence of cardiac and pulmonary complications. Thus,
this approach of epidural analgesia is recommended in the
German guidelines on analgesia and sedation in the ICU [12].
In total, two thirds (67%) of those taking part in the present
survey reported changes in analgesia and sedation manage-
ment since the last inquiry. Changes were induced by recent
literature, scientific lectures, publication of national guidelines
in 2005 [12], and a change in departmental leadership. Nev-
ertheless, this current survey merely demonstrates that knowl-
edge regarding analgesia and sedation policy has changed.
Whether a real change in practice has occurred at the
patient's bedside cannot be stated with certainty. In the imple-
mentation of guidelines in health care, large barriers to change
exist [33], and so all parties of interest must be involved and
motivated in order to effect changes in the daily treatment
routine [34]. To evaluate actual analgesia and sedation prac-
tice, patient-centered investigations similar to those of Martin
and colleagues [24] and Payen and colleagues [35] are
needed.
Conclusion
These results show that changes in analgesia and sedation
practice among intensive care patients have taken place by
the time of this survey, which was conducted 4 years after the
initial investigation and 1 year after the appearance of national
guidelines. In summary, the increased use of scoring systems
for pain severity and sedation depth, a daily sedation break,
the implementation of protocols, and the use of more short-
acting medications for analgesia and sedation conform to the
guidelines on patient-oriented analgesia and sedation.
Although we see some areas of improvement, further efforts
are necessary to reach widespread implementation of the
analgesia and sedation guidelines into practice. Further
patient-centered studies are needed to determine the extent to
which these changes translate into performance at the
patient's bedside. As wide variations in sedation practice exist
internationally [10], further national investigations are needed
to improve national sedation and analgesia policies, and, in the
long run, to yield international consensus.
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Table 5
Comparison of the techniques and agents used for analgesia and sedation in 2002 and 2006
Less than 24 hours 24 to 72 hours
Percentage (95% CI) P value Percentage (95% CI) P value
Year 2002 n = 220 2006 n = 214 2002 n = 220 2006 n = 214
Midazolam 45.9 (36.1 to 55.6) 34.6 (23.7 to 45.4) <0.001 77.3 (71.0 to 83.6) 62.2 (53.9 to 70.4) <0.001
Propofol 81.4 (75.7 to 87.1) 82.7 (77.1 to 88.3) 0.6 55,9 (47.2 to 64.7) 67.3 (59.6 to 74.9) <0.001
Remifentanil 5.9 (-6.9 to 18.7) 16.8 (4.6 to 29.0) <0.001 2.3 (-10.8 to 15.3) 7.9 (-4.9 to 20.8) <0.002
Fentanyl 40.0 (29.8 to 50.3) 27.1 (15.7 to 38.5) <0.001 55.9 (47.1 to 64.7) 40.7 (30.3 to 51.0) <0.001
Sufentanil 35.0 (24.4 to 45.7) 41.6 (31.4 to 51.8) <0.05 47.7 (38.2 to 57.3) 58.4 (49.8 to 67.1) <0.002
Piritramide 38.2 (27.8 to 48.6) 35.1 (24.3 to 45.8) 0.3 15.5 (3.3 to 27.6) 16.8 (4.6 to 29.0) 0.6
Morphine 8.6 (-4.0 to 21.3) 7.5 (-5.4 to 20.4) 0.5 4.5 (-8.4 to 17.5) 7.9 (-4.9 to 20.8) 0.06
PCA 25.5 (14.0 to 36.9) 28.5 (17.2 to 39.8) 0.3 15.5 (3.3 to 27.6) 21.5 (9.6 to 33.4) <0.001
Ketamine (S) 6.8 (-5.9 to 19.6) 14.5 (2.1 to 26.9) 0.001 20.0 (8.2 to 31.8) 25.7 (14.2 to 37.2) <0.001
Clonidine 35.9 (25.3 to 46.5) 33.6 (22.7 to 44.6) 0.5 48.2 (38.7 to 57.7) 49.5 (40.0 to 59.1) 0.7
NSAIDs 26.8 (15.6 to 38.2) 23.8 (12.1 to 35.5) 0.3 13.2 (0.8 to 25.5) 16.8 (4.6 to 29.0) 0.1
NMBAs 3.6 (-9.3 to 16.6) 0.0 0.5 0.0 0.0 n.c.
PNB 15.5 (3.3 to 27.6) 23.8 (12.1 to 35.5) 0.004 12.7 (0.4 to 25.1) 22.0 (10.1 to 33.8) <0.001
PCEA 7.3 (-5.5 to 20.0) 11.7 (-0.9 to 24.3) 0.04 5.9 (-6.9 to 18.7) 9.8 (-2.9 to 22.5) 0.05
Epidural 68.2 (60.8 to 75.7) 72.0 (64.9 to 79.1) 0.5 59.1 (50.7 to 67.6) 73.8 (67.0 to 80.7) <0.001
The chi-square test was used to calculate p values. CI, confidence interval; n, number of positive answers; n.c., not calculated; NMBAs, 
neuromuscular blocking agents; NSAIDs, non-steroidal anti-inflammatory drugs; PCA, patient-controlled analgesia; PCEA, patient-controlled 
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Key messages
￿  According to our 2006 follow-up survey of German 
intensive care units, the following changes have 
occurred since 2002:
 Increased use of scoring systems for pain severity and 
sedation depth.
 Use of more short-acting medications for analgesia and 
sedation.
 A trend toward conformity with the national guidelines on 
patient-oriented analgesia and sedation.
￿  Also according to our follow-up survey, a daily sedation 
break is currently employed in only 34% of the 
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